Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Bambusa Therapeutics, Inc.

Bambusa Therapeutics, Inc.

Series ABoston, MABiotechnology
Facts
Year of incorporation
2024sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
4
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
5
Financing history
4 rounds
  1. Nov 17, 2025
    Series A-2 · amount undisclosed
    RA Capital Management, LP (participant)Ince Capital Ltd. (participant)Redmile Group (participant)BVF Partners L (participant)ATHOS KG (participant)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “Bambusa Therapeutics Announces Completion of Series A-2 Financing to Accelerate Next-Generation Bispecific Programs”
  2. Feb 12, 2025
    Form D equity offering · $53.3M (form d sold) · 16 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Bambusa Therapeutics, Inc. filed Form D: $53,267,941 sold of $88,879,860, Biotechnology”
  3. Jun 12, 2024
    Form D equity offering · $9.0M (form d sold) · 9 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Bambusa Therapeutics, Inc. filed Form D: $8,999,974 sold of $8,999,974, Biotechnology”
  4. Jun 12, 2024
    Form D equity offering · $5.1M (form d sold) · 4 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Bambusa Therapeutics, Inc. filed Form D: $5,099,997 sold of $5,099,997, Biotechnology”
Investors on record
5 edges
People
1 officers, 3 directors
Timeline
4
  1. Nov 17, 2025
    Bambusa Therapeutics announced Series A-2
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
  2. Feb 26, 2025
    Bambusa Therapeutics, Inc. filed Form D: $53,267,941 sold of $88,879,860, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  3. Jan 8, 2025
    Bambusa Therapeutics, Inc. filed Form D: $8,999,974 sold of $8,999,974, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  4. Jan 8, 2025
    Bambusa Therapeutics, Inc. filed Form D: $5,099,997 sold of $5,099,997, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
34 observations
Every observation on this company